Good morning and hello to those who might be watching the show on either Twitch or on YouTube today.

And it is brought to you there by Springer's Jewelers.

Over a century at Springers in Tax Free Portsmouth, New Hampshire,

they have been New England's most trusted destination for diamonds

and fine watches.

So when it matters most, trust Springers.

And you can go to Springersjewlers.com to learn more.

We will get to, they said it, in about 15 minutes.

And hear from LeBron James on his future after the sweep was completed last night.

But in the meantime, some leads left this morning, including this one from Meggo.

Hello, Meggo.

Hello, good morning.

So I was thinking about doing a Celtics lead related to Janus, but I thought we're probably going to be talking about that later in the show and I came across this study from are you guys familiar with Rice University in Texas? Yeah Houston. Yeah it's a great school. The owls. They just released this study and I thought this feels very true to the way that I hear people talk about this particular subject.

And I wonder if you guys agree.

So they found that people who have used GLP1 drugs to lose weight face more judgment than if they hadn't lost any weight at all.

So they gave a fictional example in this study to 600 people who were randomly chosen,

and they said this is a 38-year-old who's been struggling with obesity since adolescence,

and they gave them a couple of different scenarios.

Either they lost weight with diet and exercise, they didn't lose weight at all,

or they lost weight with GLP-1s like OZembeke-Wagovi. And people were the harshest on the

Ozempic-Wagovi weight loss. And at this point, we've got, I think, 12% of the American

population on these drugs. The obesity rate has fallen to 37% from almost 40% a

...